Human plasma platelet-derived exosomes: Effects of aspirin

FASEB Journal

Volumn 30, Issue 5, 2016, Pages 2058-2063

  Goetzl, Edward J ^a,b   Goetzl, Laura ^c   Karliner, Joel S ^d   Tang, Norina ^d   Pulliam, Lynn ^a,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Jewish Home of San Francisco   (United States)

^c TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Atherosclerosis; Chemokines; Glycoproteins; HMGB1; Intercellular communication

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT;

CELL CULTURE; DRUG EFFECTS; EXOSOME; HUMAN; PHYSIOLOGY; THROMBOCYTE;

ASPIRIN; BLOOD PLATELETS; CELLS, CULTURED; EXOSOMES; HUMANS; PLATELET AGGREGATION INHIBITORS;

EID: 84966389357     PISSN: 08926638     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.201500150R     Document Type: Article

References (19)

1. Heijnen,H.F.,Schiel,A.E.,Fijnheer,R.,Geuze,H.J.,andSixma J.J. (1999) Activated platelets release two types of membrane vesicles: microvesicles by surface shedding and exosomes derived from exocytosis of multivesicular bodies and alpha-granules. Blood 94, 3791-3799
2. Aatonen, M. T., Ohman, T., Nyman, T. A., Laitinen, S., Grönholm, M., and Siljander, P. R. (2014) Isolation and characterization of platelet-derived extracellular vesicles. J. Extracell. Vesicles 3, 24692
3. Burnouf,T.,Goubran,H.A.,Chou,M.L.,Devos,D.,andRadosevic, M. (2014) Platelet microparticles: detection and assessment of their paradoxical functional roles in disease and regenerative medicine. Blood Rev. 28,155-166
4. Von Hundelshausen, P., and Schmitt, M. M. (2014) Platelets and their chemokines in atherosclerosis-clinical applications. Front. Physiol. 5,294
5. Huber, H. J., and Holvoet, P. (2015) Exosomes: emerging roles in communication between blood cells and vascular tissues during atherosclerosis. Curr. Opin. Lipidol. 26, 412-419
6. Lawson, C., Vicencio, J. M., Yellon, D. M., and Davidson, S. M. (2016) Microvesicles and exosomes: new players in metabolic and cardiovascular disease. J. Endocrinol. 228, R57-R71
7. Rautou, P. E., Vion, A. C., Amabile, N., Chironi, G., Simon, A., Tedgui, A., and Boulanger, C. M. (2011) Microparticles, vascular function, and atherothrombosis. Circ. Res. 109, 593-606
8. Lukasik, M., Rozalski, M., Luzak, B., Michalak, M., Ambrosius, W., Watala, C., and Kozubski, W. (2013) Enhanced platelet-derived microparticle formation is associated with carotid atherosclerosis in convalescent stroke patients. Platelets 24, 63-70
9. Mause, S. F., von Hundelshausen, P., Zernecke, A., Koenen, R. R., and Weber, C. (2005) Platelet microparticles: a transcellular delivery system for RANTES promoting monocyte recruitment on endothelium. Arterioscler. Thromb. Vasc. Biol. 25, 1512-1518
10. Lievens, D., and von Hundelshausen, P. (2011) Platelets in atherosclerosis. Thromb. Haemost. 106, 827-838
11. Kaplan, Z. S., and Jackson, S. P. (2011) The role of platelets in atherothrombosis. Hematology (Am. Soc. Hematol. Educ. Program) 2011, 51-61
12. Fiandaca, M. S., Kapogiannis, D., Mapstone, M., Boxer, A., Eitan, E., Schwartz,J.B.,Abner,E.L.,Petersen,R.C.,Federoff,H.J.,Miller, B. L., and Goetzl, E. J. (2015) Identification of preclinical Alzheimer's disease by a profile of pathogenic proteins in neurally derived blood exosomes: A case-control study. Alzheimers Dement. 11, 600-607.e1
13. Kapogiannis, D., Boxer, A., Schwartz, J. B., Abner, E. L., Biragyn, A., Masharani, U., Frassetto, L., Petersen, R. C., Miller, B. L., and Goetzl, E. J. (2015) Dysfunctionally phosphorylated type 1 insulin receptor substrate in neural-derived blood exosomes of preclinical Alzheimer'sdisease.FASEB J. 29,589-596
14. Goetzl, E. J., Boxer, A., Schwartz, J. B., Abner, E. L., Petersen, R. C., Miller, B. L., and Kapogiannis, D. (2015) Altered lysosomal proteins in neural-derived plasma exosomes in preclinical Alzheimer disease. Neurology 85,40-47
15. Kaplan, K. L., Broekman, M. J., Chernoff, A., Lesznik, G. R., and Drillings, M. (1979) Platelet a-granule proteins: studies on release and subcellular localization. Blood 53,604-618
16. Fiuza, C., Bustin, M., Talwar, S., Tropea, M., Gerstenberger, E., Shelhamer, J. H., and Suffredini, A. F. (2003) Inflammationpromoting activity of HMGB1 on human microvascular endothelial cells. Blood 101, 2652-2660
17. Yang,X.,Wang,H.,Zhang,M.,Liu,J.,Lv,B.,andChen,F.(2015) HMGB1: a novel protein that induced platelets active and aggregation via Toll-like receptor-4, NF-kB and cGMP dependent mechanisms. Diagn. Pathol. 10,134
18. Vogel, S., Bodenstein, R., Chen, Q., Feil, S., Feil, R., Rheinlaender, J., Schäffer, T. E., Bohn, E., Frick, J. S., Borst, O., Münzer, P., Walker, B., Markel,J.,Csanyi,G.,Pagano,P.J.,Loughran,P.,Jessup,M.E.,Watkins, S.C.,Bullock,G.C.,Sperry,J.L.,Zuckerbraun,B.S.,Billiar,T.R.,Lotze, M. T., Gawaz, M., and Neal, M. D. (2015) Platelet-derived HMGB1 is a critical mediator of thrombosis. J. Clin. Invest. 125, 4638-4654
19. Goetzl, E. J., Boxer, A., Schwartz, J. B., Abner, E. L., Petersen, R. C., Miller, B. L., Carlson, O. D., Mustapic, M., and Kapogiannis, D. (2015) Low neural exosomal levels of cellular survival factors in Alzheimer'sdisease.Ann. Clin. Transl. Neurol. 2,769-773